Men and women both will find a number of alarming concepts in the gender-flipping comedy “Ladies First,” not the least of which will be the idea of Sacha Baron Cohen as a romantic lead. He’s a ...

Jeff Bezos delivered a backhanded compliment to President Donald Trump, saying he's more mature now than during his first term. In an exclusive interview with CNBC, Bezos was asked to explain how he ...

Managing complement 3 glomerulopathy involves several treatment options aimed at slowing disease progression and protecting kidney function. These may include blood pressure control, steroids, ...

If I’m being honest, I must say that I didn’t exactly love the way that the last run of Bond films wrapped up. To be clear, I’m not down on Daniel Craig. In fact, like many fans, I’m of the opinion ...

The Carolina Panthers have gone to great lengths to fix the interior of their defense since that dreadful 2024 season. That year, they allowed the most points in NFL history thanks in no small part to ...

The final stretch of the 2026 Kentucky Derby saw race favorite Renegade and longshot Golden Tempo surge forward, with Golden Tempo getting a historic win. It was a thrilling finish, and also a big day ...

Copyright: © 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies. Against this backdrop, the ...

There’s exciting news for Married At First Sight fans as Channel 4 have just confirmed that spin-off series is in the works. Second Marriage At First Sight will see former brides and grooms from ...

Although the Celtics and Philadelphia 76ers met four times during the regular season, each team will have a different look Sunday afternoon when they meet in Boston for Game 1 of their Eastern ...

No, it’s not a typo in the box score. Fernando Tatis Jr. was the Padres’ starting second baseman Saturday night in San Diego. Seemingly out of nowhere, Tatis -- the two-time Platinum Glove ...

The Opti-GAIN study from Complement Therapeutics is assessing the safety, tolerability, and preliminary efficacy in GA secondary to age-related macular degeneration (AMD) of CTx001. A first-in-human ...

First patient dosed in Opti-GAIN, a first-in-human Phase I/II clinical trial of CTx001 in Geographic Atrophy secondary to AMD Complement Therapeutics GmbH (CTx), a clinical-stage biotechnology company ...